Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HP Inc (HPQ) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

HP Inc vs Vaxcyte Inc. Common Stock — how do they compare? HP Inc trades at $30.49 (market cap $27.62B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: HP Inc is far larger — about 2.6× Vaxcyte Inc. Common Stock's market cap, and HP Inc pays a 3.92% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HP Inc for 70 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

HPQPCVX
Market Cap
$27.62B$10.51B
Volume
12,820,0662,644,694
Sector
TechnologyHealth
52-Week High
$35.48$73.82
52-Week Low
$18.20$40.32
Typical Hold Time
70 Days0 Days
Enterprise Value
$33.79B$9.14B
Dividend Yield
3.92%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HP Inc

HPQ trades at $30.46, up 1.98% today, with a bearish technical signal despite recent earnings beats. The company maintains stable cash flow generation ($460M net in 2025) and pays a $0.30 dividend, but faces PC market headwinds with 2027 industry volume declines projected. Valuation appears reasonable with P/E of 11.69 and P/S of 0.48, though negative shareholder equity raises concerns.

The outlook is mixed: attractive valuation and dividend yield support the stock, but PC market challenges and negative equity position create significant risks. Analyst consensus is cautious with a $25.75 price target below current levels, suggesting limited near-term upside potential amid industry uncertainty.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HPQ
56% Buy44% Sell
Avg holding period · 70 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About HP Inc

HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.

Read more on HPQ →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →